HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shiseido Aims To Be World’s No. 1 ‘Skin Beauty’ Company By 2030

Executive Summary

With makeup and lipstick sales down globally at a time of wide mask use, Shiseido is focused on skin health, planning launches to address sensitive skin needs and heightened demand for cleansing and protection effects. In August, the firm projected a 16% decline in net sales for full-year fiscal 2020.

You may also be interested in...



Shiseido Reinforces US Position, Taps Dermocosmetics Growth With Dr. Dennis Gross Acquisition

Acquisition of the doctor-led “#1 At-Home Peel” brand continues Shiseido’s work to build its Americas business and strengthens its game in the dermocosmetics space, which has been growing fast since the pandemic. The firm’s net sales in the first nine months of 2023 increased 5% like-for-like to ¥722.4bn.

Top Beauty Companies Announce Paper Packaging Progress; Sustainability News In Brief

A growing number of cosmetics companies are throwing out plastic packaging once and for all. Estee Lauder Companies and e.l.f. Cosmetics announce the latest in their transition to sustainable paper packaging, while Shiseido highlights its ocean conservation work.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150484

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel